» Articles » PMID: 29078319

PTIP Chromatin Regulator Controls Development and Activation of B Cell Subsets to License Humoral Immunity in Mice

Overview
Specialty Science
Date 2017 Oct 29
PMID 29078319
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

B cell receptor signaling and downstream NF-κB activity are crucial for the maturation and functionality of all major B cell subsets, yet the molecular players in these signaling events are not fully understood. Here we use several genetically modified mouse models to demonstrate that expression of the multifunctional BRCT (BRCA1 C-terminal) domain-containing PTIP (Pax transactivation domain-interacting protein) chromatin regulator is controlled by B cell activation and potentiates steady-state and postimmune antibody production in vivo. By examining the effects of PTIP deficiency in mice at various ages during ontogeny, we demonstrate that PTIP promotes bone marrow B cell development as well as the neonatal establishment and subsequent long-term maintenance of self-reactive B-1 B cells. Furthermore, we find that PTIP is required for B cell receptor- and T:B interaction-induced proliferation, differentiation of follicular B cells during germinal center formation, and normal signaling through the classical NF-κB pathway. Together with the previously identified role for PTIP in promoting sterile transcription at the locus, the present results establish PTIP as a licensing factor for humoral immunity that acts at several junctures of B lineage maturation and effector cell differentiation by controlling B cell activation.

Citing Articles

A novel glycolysis-related gene signature for predicting the prognosis of multiple myeloma.

Zhang B, Wang Q, Lin Z, Zheng Z, Zhou S, Zhang T Front Cell Dev Biol. 2023; 11:1198949.

PMID: 37333985 PMC: 10272536. DOI: 10.3389/fcell.2023.1198949.


Pax transactivation domain-interacting protein is required for preserving hematopoietic stem cell quiescence via regulating lysosomal activity.

Zhang T, Cui M, Li Y, Cheng Y, Gao Z, Wang J Haematologica. 2023; 108(9):2410-2421.

PMID: 36924252 PMC: 10483346. DOI: 10.3324/haematol.2022.282224.


Bioinformatics-based analysis of potential candidates chromatin regulators for immune infiltration in osteoarthritis.

Wang W, Ou Z, Peng J, Wang N, Zhou Y BMC Musculoskelet Disord. 2022; 23(1):1123.

PMID: 36550476 PMC: 9783407. DOI: 10.1186/s12891-022-06098-8.


Acetyltransferases GCN5 and PCAF Are Required for B Lymphocyte Maturation in Mice.

Oksenych V, Su D, Daniel J Biomolecules. 2022; 12(1).

PMID: 35053209 PMC: 8773862. DOI: 10.3390/biom12010061.


B cell engagement with HIV-1 founder virus envelope predicts development of broadly neutralizing antibodies.

Townsley S, Donofrio G, Jian N, Leggat D, Dussupt V, Mendez-Rivera L Cell Host Microbe. 2021; 29(4):564-578.e9.

PMID: 33662277 PMC: 8245051. DOI: 10.1016/j.chom.2021.01.016.


References
1.
Daniel J, Nussenzweig A . The AID-induced DNA damage response in chromatin. Mol Cell. 2013; 50(3):309-21. PMC: 3658174. DOI: 10.1016/j.molcel.2013.04.017. View

2.
Ward I, Reina-San-Martin B, Olaru A, Minn K, Tamada K, Lau J . 53BP1 is required for class switch recombination. J Cell Biol. 2004; 165(4):459-64. PMC: 2172356. DOI: 10.1083/jcb.200403021. View

3.
Castro I, Wright J, Damdinsuren B, Hoek K, Carlesso G, Shinners N . B cell receptor-mediated sustained c-Rel activation facilitates late transitional B cell survival through control of B cell activating factor receptor and NF-kappaB2. J Immunol. 2009; 182(12):7729-37. PMC: 2770265. DOI: 10.4049/jimmunol.0803281. View

4.
Zhang Z, Huang L, Zhao W, Rigas B . Annexin 1 induced by anti-inflammatory drugs binds to NF-kappaB and inhibits its activation: anticancer effects in vitro and in vivo. Cancer Res. 2010; 70(6):2379-88. PMC: 2953961. DOI: 10.1158/0008-5472.CAN-09-4204. View

5.
Gerondakis S, Siebenlist U . Roles of the NF-kappaB pathway in lymphocyte development and function. Cold Spring Harb Perspect Biol. 2010; 2(5):a000182. PMC: 2857169. DOI: 10.1101/cshperspect.a000182. View